BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3055254)

  • 1. Prostate carcinoma investigated by whole organ sections using the Gleason histologic grading system.
    Hostetter A; Pedersen K; Boeryd B; Gustafsson B; Månson J; Engberg A
    Scand J Urol Nephrol Suppl; 1988; 110():163-7. PubMed ID: 3055254
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
    Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
    Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histologic grading of primary prostatic carcinoma--study of Gleason histologic grading].
    Uchijima Y; Kusuyama H; Okada K
    Hinyokika Kiyo; 1987 Aug; 33(8):1193-8. PubMed ID: 3425519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histological study of cancer of the prostate].
    Romero Aguirre F; Sanz Esponera J; Lázaro Pérez J; Romero Fernández FJ
    Arch Esp Urol; 1981; 34(5):339-46. PubMed ID: 7036919
    [No Abstract]   [Full Text] [Related]  

  • 6. New developments in grading prostate cancer.
    Miller GJ
    Semin Urol; 1990 Feb; 8(1):9-18. PubMed ID: 2189192
    [No Abstract]   [Full Text] [Related]  

  • 7. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
    Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.
    Epstein JI; Allsbrook WC; Amin MB; Egevad LL
    Adv Anat Pathol; 2006 Jan; 13(1):57-9. PubMed ID: 16462155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glandular profiles and cellular patterns in prostatic cancer grading. National Prostatic Cancer Project System.
    Gaeta JF
    Urology; 1981 Mar; 17(Suppl 3):33-7. PubMed ID: 7210369
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostatic carcinoma: histopathologic classification, grading, receptors and markers.
    Capelli A; Carbone A
    Rays; 1993; 18(1):23-32. PubMed ID: 8356238
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
    Rubin MA; Mucci NR; Manley S; Sanda M; Cushenberry E; Strawderman M; Montie JE; Bassily NH
    J Urol; 2001 Jan; 165(1):114-8. PubMed ID: 11125378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological profile, histogenesis and biological assessment of clear-cell microcarcinoma of the prostate].
    Linoli O
    Pathologica; 1984; 76(1041):21-33. PubMed ID: 6379585
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignancy grade and clinical stage T0-T3 in prostate cancer].
    Wernert N; Goebbels R; Dhom G
    Urologe A; 1986 Jan; 25(1):55-8. PubMed ID: 3962046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thin-needle aspiration biopsy of the prostate.
    Koss LG; Woyke S; Schreiber K; Kohlberg W; Freed SZ
    Urol Clin North Am; 1984 May; 11(2):237-51. PubMed ID: 6203204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gleason histologic grading of prostate carcinoma in relation to serum PSA, PSA in situ and immunohistochemical expression of 34 beta E12 and P504S].
    Xiao Q; Yin H; Lu Z; Meng K; Zhou X
    Zhonghua Nan Ke Xue; 2004 May; 10(5):362-5. PubMed ID: 15190830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frozen section diagnosis and mucin production in prostatic carcinoma.
    Schaefer JA; Lilien OM; Sandler M
    Invest Urol; 1969 Mar; 6(5):493-504. PubMed ID: 4887492
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C
    Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.